Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma
- 1 September 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 160 (3) , 242-244
- https://doi.org/10.1016/s0002-9610(06)80015-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 5-fluorouracil and uft-sensitive gastric carcinoma has a high level of thymidylate synthaseCancer, 1990
- Report on nationwide pooled data and cohort investigation in UFT phase II studyCancer Chemotherapy and Pharmacology, 1988
- Long‐term survival in Japanese patients with far advanced carcinoma of the stomachWorld Journal of Surgery, 1988
- UFT Is More Antineoplastic against Gastric Carcinoma than 5-Fluorouracil, 1-(2-Tetrahydrofuryl)-5-fluorouracil and 1-Hexylcarbamoyl-5-FluorouracilChemotherapy, 1988
- Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracilCancer, 1987
- Postoperative adjuvant chemotherapy for gastric cancer, the second report. Analysis of data on 2873 patients followed for five yearsSurgery Today, 1986
- Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomachSurgery Today, 1981
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981